|
10004
|
Biotium
|
BCIP Red (5-Bromo-6-chloro-3-indoxyl phosphate, p-toluidine salt)
|
|
|
|
|
AR4010-50
|
Boster Biological Technology
|
Caspase-10 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4004-50
|
Boster Biological Technology
|
Caspase-2 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4005-50
|
Boster Biological Technology
|
Caspase-3, 7 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4006-50
|
Boster Biological Technology
|
Caspase-4 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4009-50
|
Boster Biological Technology
|
Caspase-6 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4007-50
|
Boster Biological Technology
|
Caspase-8 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
AR4008-50
|
Boster Biological Technology
|
Caspase-9 Activity Assay Kit [50 assays]
|
|
Enzyme Activity
|
|
|
HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-116022A-1g
|
MedChemexpress LLC
|
4-Nitrophenyl phosphate (disodium hexahydrate) [CAS 333338-18-4]
|
|
|
|
|
HY-120833-1mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-120833-10mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-120833-25mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-120833-5mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-13440-1mg
|
MedChemexpress LLC
|
AMG 511 [CAS 1253573-53-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-13440-5mg
|
MedChemexpress LLC
|
AMG 511 [CAS 1253573-53-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-13440-1mL
|
MedChemexpress LLC
|
AMG 511 [CAS 1253573-53-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-128204-10mg
|
MedChemexpress LLC
|
AN3661 [CAS 1268335-33-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-128204-25mg
|
MedChemexpress LLC
|
AN3661 [CAS 1268335-33-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-128204-5mg
|
MedChemexpress LLC
|
AN3661 [CAS 1268335-33-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-128204-1mL
|
MedChemexpress LLC
|
AN3661 [CAS 1268335-33-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-147198-1mg
|
MedChemexpress LLC
|
Antimalarial agent 13 [CAS 431884-01-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-19502-1mg
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19502-10mg
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8]
|
|
COVID-19-immunoregulation
|
|
